Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Denali Therapeutics in a research report issued to ...

Jefferies (NYSE:JEF) analyst Michael Yee maintained a Buy rating on Denali Therapeutics (NASDAQ:DNLI) on Sunday, setting a price target of $95, which is approximately 48.67%... Evercore ISI ...

Buy DNLI near 21.99 target 26.25 stop loss @ 21.93 Details The technical summary data tells us to buy DNLI near 21.99 with an upside target of 26.25. This data also tells us to set a stop loss @ 21.93 ...

After hours: January 24 at 4:52:31 PM EST Loading Chart for DNLI ...

After hours: January 27 at 6:44:31 PM EST ...

Carole Ho, the Chief Medical (TASE:PMCN) Officer of Denali Therapeutics Inc. (NASDAQ:DNLI), has recently sold shares of the company's common stock, according to a filing... On January 6 and 7, Ryan J.

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's ...

Jan. 23, 2025 — While climate change is likely to present significant challenges to agriculture in coming decades, it could also mean that crops such as chickpeas, ... Revolutionizing Ammonia ...

Steep new fines — more than many people make in a month — have made the streets of Ho Chi Minh City and Hanoi less freewheeling than they used to be. By Damien Cave When Colombia’s ...

Disgusted by Democrats’ ongoing support for the genocide in Gaza, some Muslim and Arab American voters are embracing third-party candidates and community-based forms of political engagement ...